Development and pharmacological evaluation of liposomes and nanocapsules containing paroxetine hydrochloride
Raquel Chiarentin(Universidade Feevale), Cristiane Bastos de Mattos(Universidade Feevale), Simone Gasparín Verza(Universidade Feevale), Mariele Feiffer Charão(Universidade Feevale), Gabriel da Costa Berna(Universidade Feevale), Fernanda Neutzling Kaufmann(Universidade Católica de Pelotas), Juliane Deise Fleck(Universidade Feevale), Thalia Emmanoella Sebulsqui Saraiva(Universidade Feevale), Bruna Saraiva Hermann(Universidade Feevale), Bruna Zeni(Universidade Feevale), Carolina Grave(Universidade Feevale), Giulia Aline Führ(Universidade Feevale), Bruna Hoffmeister(Universidade Feevale), Andresa Heemann Betti(Universidade Feevale), Dienifer Pereira Bottcher(Universidade Feevale), Fernando Dal Pont Morisso(Universidade Feevale)
Cited by 6
Related Papers
NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findings
|Brain Behavior and Immunity|2017|375
Neurobiology of resilience in depression: immune and vascular insights from human and animal studies
|European Journal of Neuroscience|2019|153
Depression and peripheral inflammatory profile of patients with obesity
|Psychoneuroendocrinology|2018|103
Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats
|European Journal of Pharmacology|2014|98
Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings
|European Journal of Pharmacology|2016|73